Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Amlo Biosciences
company
About
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- £2.45M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£2.45M
Amlo Biosciences has raised a total of
£2.45M
in funding over 2 rounds. Their latest funding was raised on
Apr 21, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 21, 2022 | Series Unknown | £2.45M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Amlo Biosciences is funded by 1 investors.
Ascension Life Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Ascension Life Fund
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
